BioCentury
ARTICLE | Company News

Vivalis, Chemo-Sero-Therapeutic Research Institute deal

September 12, 2005 7:00 AM UTC

Vivalis granted the institute rights to evaluate the company's EBx chicken embryonic-derived stem cell lines (EBx) for production of human and animal vaccines. Terms were not disclosed. ...